Pioglitazone hydrochloride

Details Pioglitazone hydrochloride Pioglitazone hydrochloride

2006-11-14

2006-11-14

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S269700, C514S342000

Reexamination Certificate

active

07135485

ABSTRACT:
Provided is a novel crystal form of pioglitazone hydrochloride and a method for making it. Also provided is a method for making a known crystal form of pioglitazone hydrochloride.

REFERENCES:
patent: 4687777 (1987-08-01), Meguro et al.
patent: 5585495 (1996-12-01), Huber
patent: 5700820 (1997-12-01), Vyas et al.
patent: 5952509 (1999-09-01), Saito et al.
patent: WO-0228857 (2001-09-01), None
Concise Encyclopedia Chemistry (1994) Walter de Gruyter, Berlin-New York, pp. 872-873.
A. Maureen Rouhi, Chemical & Engineering News, Feb. 24, 2003, pp. 32-35.
G. M. Wall, “Pharmaceutical Applications of Drug Crystal Studies,” Pharmaceutical Manufacturing, vol. 3, No. 2, Feb. 1986, pp. 33-42.
J. Haleblian and W. McCrone, “Pharmaceutical Applications of Polymorphism,” Journal of Pharmaceutical Sciences, vol. 58, No. 8, Aug. 1969, pp. 911-929J. Pharm. Sci., 58,911 (1969).
J.K. Haleblian, “Characterization of Habits and Crystalline Modification of Solids and Their Pharmaceutical Applications,” Journal of Pharmaceutical Sciences, vol. 64, No. 8, Aug. 1975, pp. 1269-1288.

Affiliated with

Also associated with

Rating

Pioglitazone hydrochloride does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pioglitazone hydrochloride, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pioglitazone hydrochloride will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3661928